Skip to main content
Fig. 5 | BMC Developmental Biology

Fig. 5

From: Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells

Fig. 5

qRT-PCR assessment of PGE-2, IDO and panHLA-G. All the tissue specific hMSCs were treated with Dex at different dose concentration and time points a Fold change of PGE-2; Shows the significant upregulation in BM-MSCs and DP-MSCs at 24 h, whereas AD-MSCs and UC-MSCs did not respond for Dex in terms of PGE-2 expression, b Fold change of IDO; shows the significant upregulation in BM-MSC and AD-MSCs at 48 h, similarly, DP-MSCs shows significant upregulation at 1000 ng/ml for 48 h, whereas, UC-MSCs did not shows any significant upregulation, c Fold change of HLA-G; HLA-G did not shows any significant upregulation in all the dose and time point. Data from five donors and shown as mean ± SD; ***p < 0.001, **p < 0.01, *p < 0.05

Back to article page